State of Wyoming Acquires 11,386 Shares of Amrize Ltd $AMRZ

State of Wyoming lifted its holdings in Amrize Ltd (NYSE:AMRZ) by 1,725.2% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 12,046 shares of the company’s stock after purchasing an additional 11,386 shares during the period. State of Wyoming’s holdings in Amrize were worth $651,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the business. TD Asset Management Inc lifted its stake in shares of Amrize by 1.4% in the 4th quarter. TD Asset Management Inc now owns 153,280 shares of the company’s stock worth $8,348,000 after purchasing an additional 2,104 shares during the period. Transatlantique Private Wealth LLC purchased a new stake in Amrize in the 4th quarter worth approximately $159,000. CIBC Asset Management Inc increased its holdings in Amrize by 345.1% in the 4th quarter. CIBC Asset Management Inc now owns 26,677 shares of the company’s stock worth $1,443,000 after acquiring an additional 20,684 shares in the last quarter. BW Gestao de Investimentos Ltda. purchased a new stake in Amrize in the 4th quarter worth approximately $7,109,000. Finally, Monaco Asset Management SAM purchased a new stake in Amrize in the 4th quarter worth approximately $2,434,000.

Insider Activity at Amrize

In related news, CTO Roald Brouwer acquired 1,500 shares of the business’s stock in a transaction on Thursday, May 21st. The stock was acquired at an average cost of $49.84 per share, with a total value of $74,760.00. Following the acquisition, the chief technology officer directly owned 19,757 shares in the company, valued at $984,688.88. This represents a 8.22% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Nollaig Forrest acquired 2,000 shares of the business’s stock in a transaction on Friday, May 22nd. The shares were bought at an average cost of $50.25 per share, with a total value of $100,500.00. Following the completion of the acquisition, the insider owned 20,139 shares in the company, valued at approximately $1,011,984.75. This represents a 11.03% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last 90 days, insiders acquired 71,554 shares of company stock valued at $3,669,069. Corporate insiders own 0.54% of the company’s stock.

Amrize Trading Down 1.6%

Shares of AMRZ opened at $53.49 on Friday. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.40 and a quick ratio of 0.89. Amrize Ltd has a 1 year low of $44.12 and a 1 year high of $65.94. The company has a 50 day simple moving average of $54.36 and a two-hundred day simple moving average of $55.31. The firm has a market cap of $29.58 billion and a P/E ratio of 25.59.

Amrize (NYSE:AMRZ) last announced its quarterly earnings data on Wednesday, April 29th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02). Amrize had a net margin of 9.70% and a return on equity of 9.84%. The company had revenue of $2.18 billion for the quarter. The firm’s revenue for the quarter was up 4.7% compared to the same quarter last year. On average, equities analysts expect that Amrize Ltd will post 2.76 earnings per share for the current fiscal year.

Amrize Cuts Dividend

The business also recently disclosed a dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were issued a dividend of $0.11 per share. The ex-dividend date of this dividend was Tuesday, May 12th. Amrize’s dividend payout ratio (DPR) is 21.05%.

Wall Street Analyst Weigh In

Several research firms recently issued reports on AMRZ. Weiss Ratings lowered shares of Amrize from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, May 18th. Oppenheimer set a $68.00 target price on shares of Amrize in a report on Friday, May 1st. JPMorgan Chase & Co. increased their target price on shares of Amrize from $60.00 to $70.00 and gave the stock an “overweight” rating in a report on Thursday, March 5th. Royal Bank Of Canada reduced their target price on shares of Amrize from $61.00 to $60.00 and set a “sector perform” rating for the company in a report on Friday, May 1st. Finally, Morgan Stanley reissued an “overweight” rating and issued a $65.00 target price on shares of Amrize in a report on Wednesday, May 6th. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $64.86.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.